Lumida
/LFST
⌘K
LifeStance Health Group Inc

LifeStance Health Group Inc

LFST
$11.58USD+2.57%+0.29 today

MARKET CAP

4.5B

P/E (TTM)

193.0x

FWD P/E

59.8x

DAY RANGE

$11 – $12

52W RANGE

$4
$12

AI Summary

Stalk
Buy NowMedium

LFST remains in a Stage 2 advancing uptrend, and following a steep overbought rally it has pulled back into the rising 9/21 EMA support zone. Short-term timing is favorable, warranting a buy now on this pullback. A decisive break below the EMAs would invalidate the medium-term bullish bias.

  • Q1 2026 revenue climbed 21% YoY to $403M
  • Visit volumes increased 18% YoY to 2.5M sessions
  • Profitability score indicates cost‐management issues; earnings yield is negative
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

LifeStance Health Group, Inc. (NASDAQ: LFST) is a leading provider of outpatient mental health services in the U.S., specializing in a hybrid model that encompasses both in-person and telehealth care. The company stands out with its extensive clinician network, delivering high-quality mental health treatment in an environment marked by growing societal awareness and demand for mental health services. LifeStance operates over 570 centers nationwide, positioning itself strategically within a sector that is experiencing significant growth and transformation, driven by increased recognition of mental health challenges.

Bull says

  • Q1 2026 revenue climbed 21% YoY to $403M
  • Visit volumes increased 18% YoY to 2.5M sessions
  • Net income improved to $14M from $1M YoY with $22M free cash flow
  • AI‐driven workflows and digital check-ins delivering measurable cost savings
  • Active tuck-in M&A pipeline poised to expand geographic reach
  • Positive analyst revisions and strong momentum support growth outlook

Bear says

  • Profitability score indicates cost‐management issues; earnings yield is negative
  • Volatility score of 2.52 signals potential for wide share‐price swings
  • Leverage risk elevated and liquidity metrics remain weak
  • Telehealth and specialty services face shifting regulatory requirements
  • Intense competition for clinician recruitment and retention may constrain growth
  • High valuations and macro uncertainty could limit downside cushion

Investment themes with LFST

Health Care Providers -0.61%

UNH · CVS · HCA

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-10-2026bullish

Transcript signals

Bull points

  • Across the organization, digital and AI tools, including digital patient check-in, AI-driven workflows, and robotic process automation support operational excellence, particularly in areas with heavy manual processes such as revenue cycle management.
  • AI-enabled scheduling tools support our new patient telephone booking process, resulting in converting more calls to appointments.
  • We are also rolling out AI-assisted clinical documentation to reduce administrative burden and cognitive load for clinicians, enabling them to spend more time with patients, which should improve patient and clinician satisfactions.

Bear points

  • we do not have that. So we do not have that capability you described. That is something that we're exploring.
Read full transcript analysis ›